Literature DB >> 15717663

Lanreotide autogel is a therapeutic option for patients who develop acute pancreatitis after somatostatin analog treatment.

E Boix, P López, M Pérez-Mateo, A Picó.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15717663     DOI： 10.1007/BF03347488

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  7 in total

1.  Acute pancreatitis after short-term octreotide.

Authors:  A Fredenrich; C Sosset; J L Bernard; J L Sadoul; P Freychet
Journal:  Lancet       Date:  1991-07-06       Impact factor: 79.321

2.  Octreotide and lanreotide treatment in active acromegaly.

Authors:  S Cannavò; R Fazio; S Squadrito; F Trimarchi
Journal:  J Clin Endocrinol Metab       Date:  1997-07       Impact factor: 5.958

3.  Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: six-month report on an Italian multicentre study.

Authors:  S Soule; G Conway; A Hatfield; H Jacobs
Journal:  J Clin Endocrinol Metab       Date:  1996-12       Impact factor: 5.958

4.  Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in the management of acromegaly.

Authors:  Ph Caron; A Beckers; D R Cullen; M I Goth; B Gutt; P Laurberg; A M Pico; M Valimaki; W Zgliczynski
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

5.  Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study.

Authors:  Angelo Andriulli; Nazario Caruso; Michele Quitadamo; Rosario Forlano; Gioacchino Leandro; Fulvio Spirito; Giovanni De Maio
Journal:  JOP       Date:  2003-01

Review 6.  Antisecretory agents for prevention of post-ERCP pancreatitis: rationale for use and clinical results.

Authors:  Ronnie Tung-Ping Poon; Sheung Tat Fan
Journal:  JOP       Date:  2003-01

7.  Octreotide-induced acute pancreatitis in a patient with acquired immunodeficiency syndrome.

Authors:  J D Gradon; R H Schulman; E K Chapnick; D V Sepkowitz
Journal:  South Med J       Date:  1991-11       Impact factor: 0.954
  7 in total
  2 in total

1.  [Somatostatin analogs for the treatment of advanced, hormone-refractory prostate cancer: a possibility for secondary hormonal ablation?].

Authors:  D Schilling; R Küfer; S Kruck; A Stenzl; M A Kuczyk; A S Merseburger
Journal:  Urologe A       Date:  2008-10       Impact factor: 0.639

Review 2.  NSAIDs and Acute Pancreatitis: A Systematic Review.

Authors:  Raffaele Pezzilli; Antonio Maria Morselli-Labate; Roberto Corinaldesi
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.